Indoleamine 2,3-dioxygenase 1 is upregulated in activated microglia in mice cerebellum during acute viral encephalitis

Ayako Taguchi, Masayuki Niwa, Masato Hoshi, Kuniaki Saito, Teruaki Masutani, Kenji Hisamatsu, Kazuhiro Kobayashi, Yuichiro Hatano, Hiroyuki Tomita, Akira Hara

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Indoleamine 2,3-dioxygenase1 (IDO1) is the rate-limiting enzyme in the kynurenine pathway that converts l-tryptophan to l-kynurenine. Encephalomyocarditis virus (EMCV) can cause acute myocarditis in various animals including mice. Previously, IDO1 has been reported to have an important immunomodulatory function in immune-related diseases. However, the pathophysiological roles of IDO1 following acute viral infection of central nervous system are not fully understood. We observed that acute EMCV infection leads to a highly reproducible neuronal degeneration in mouse cerebellum. The goal of this study is to determine tissue/cell-specific and time-dependent expressions of IDO1 during acute EMCV infection in mouse cerebellum. IDO1 was up-regulated in microglia, which was recognized to be activated morphologically and positive for ionized calcium-binding adapter molecule 1 (Iba-1), a protein expressed in microglia, within EMCV-induced cerebellar lesions showing neuronal degeneration although the very weak expression of IDO1 is detected only in cytoplasm of Purkinje cells. No GFAP immunostaining was observed in EMCV-induced cerebellar lesions although many reactive astrocytes surrounding the lesions showed strongly positive immunostaining for GFAP 10 days after the viral inoculation. Thus, IDO1 expression may affect EMCV-induced neuronal degeneration in cerebellum.

Original languageEnglish
Pages (from-to)120-125
Number of pages6
JournalNeuroscience Letters
Volume564
DOIs
Publication statusPublished - 03-04-2014
Externally publishedYes

Fingerprint

Viral Encephalitis
Encephalomyocarditis virus
Indoleamine-Pyrrole 2,3,-Dioxygenase
Microglia
Cerebellum
Kynurenine
Virus Diseases
Central Nervous System Viral Diseases
Purkinje Cells
Immune System Diseases
Myocarditis
Tryptophan
Astrocytes
Cytoplasm
Calcium
Enzymes

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)

Cite this

Taguchi, Ayako ; Niwa, Masayuki ; Hoshi, Masato ; Saito, Kuniaki ; Masutani, Teruaki ; Hisamatsu, Kenji ; Kobayashi, Kazuhiro ; Hatano, Yuichiro ; Tomita, Hiroyuki ; Hara, Akira. / Indoleamine 2,3-dioxygenase 1 is upregulated in activated microglia in mice cerebellum during acute viral encephalitis. In: Neuroscience Letters. 2014 ; Vol. 564. pp. 120-125.
@article{274a5e9959d04a77bc4516420d0aa405,
title = "Indoleamine 2,3-dioxygenase 1 is upregulated in activated microglia in mice cerebellum during acute viral encephalitis",
abstract = "Indoleamine 2,3-dioxygenase1 (IDO1) is the rate-limiting enzyme in the kynurenine pathway that converts l-tryptophan to l-kynurenine. Encephalomyocarditis virus (EMCV) can cause acute myocarditis in various animals including mice. Previously, IDO1 has been reported to have an important immunomodulatory function in immune-related diseases. However, the pathophysiological roles of IDO1 following acute viral infection of central nervous system are not fully understood. We observed that acute EMCV infection leads to a highly reproducible neuronal degeneration in mouse cerebellum. The goal of this study is to determine tissue/cell-specific and time-dependent expressions of IDO1 during acute EMCV infection in mouse cerebellum. IDO1 was up-regulated in microglia, which was recognized to be activated morphologically and positive for ionized calcium-binding adapter molecule 1 (Iba-1), a protein expressed in microglia, within EMCV-induced cerebellar lesions showing neuronal degeneration although the very weak expression of IDO1 is detected only in cytoplasm of Purkinje cells. No GFAP immunostaining was observed in EMCV-induced cerebellar lesions although many reactive astrocytes surrounding the lesions showed strongly positive immunostaining for GFAP 10 days after the viral inoculation. Thus, IDO1 expression may affect EMCV-induced neuronal degeneration in cerebellum.",
author = "Ayako Taguchi and Masayuki Niwa and Masato Hoshi and Kuniaki Saito and Teruaki Masutani and Kenji Hisamatsu and Kazuhiro Kobayashi and Yuichiro Hatano and Hiroyuki Tomita and Akira Hara",
year = "2014",
month = "4",
day = "3",
doi = "10.1016/j.neulet.2014.01.051",
language = "English",
volume = "564",
pages = "120--125",
journal = "Neuroscience Letters",
issn = "0304-3940",
publisher = "Elsevier Ireland Ltd",

}

Indoleamine 2,3-dioxygenase 1 is upregulated in activated microglia in mice cerebellum during acute viral encephalitis. / Taguchi, Ayako; Niwa, Masayuki; Hoshi, Masato; Saito, Kuniaki; Masutani, Teruaki; Hisamatsu, Kenji; Kobayashi, Kazuhiro; Hatano, Yuichiro; Tomita, Hiroyuki; Hara, Akira.

In: Neuroscience Letters, Vol. 564, 03.04.2014, p. 120-125.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Indoleamine 2,3-dioxygenase 1 is upregulated in activated microglia in mice cerebellum during acute viral encephalitis

AU - Taguchi, Ayako

AU - Niwa, Masayuki

AU - Hoshi, Masato

AU - Saito, Kuniaki

AU - Masutani, Teruaki

AU - Hisamatsu, Kenji

AU - Kobayashi, Kazuhiro

AU - Hatano, Yuichiro

AU - Tomita, Hiroyuki

AU - Hara, Akira

PY - 2014/4/3

Y1 - 2014/4/3

N2 - Indoleamine 2,3-dioxygenase1 (IDO1) is the rate-limiting enzyme in the kynurenine pathway that converts l-tryptophan to l-kynurenine. Encephalomyocarditis virus (EMCV) can cause acute myocarditis in various animals including mice. Previously, IDO1 has been reported to have an important immunomodulatory function in immune-related diseases. However, the pathophysiological roles of IDO1 following acute viral infection of central nervous system are not fully understood. We observed that acute EMCV infection leads to a highly reproducible neuronal degeneration in mouse cerebellum. The goal of this study is to determine tissue/cell-specific and time-dependent expressions of IDO1 during acute EMCV infection in mouse cerebellum. IDO1 was up-regulated in microglia, which was recognized to be activated morphologically and positive for ionized calcium-binding adapter molecule 1 (Iba-1), a protein expressed in microglia, within EMCV-induced cerebellar lesions showing neuronal degeneration although the very weak expression of IDO1 is detected only in cytoplasm of Purkinje cells. No GFAP immunostaining was observed in EMCV-induced cerebellar lesions although many reactive astrocytes surrounding the lesions showed strongly positive immunostaining for GFAP 10 days after the viral inoculation. Thus, IDO1 expression may affect EMCV-induced neuronal degeneration in cerebellum.

AB - Indoleamine 2,3-dioxygenase1 (IDO1) is the rate-limiting enzyme in the kynurenine pathway that converts l-tryptophan to l-kynurenine. Encephalomyocarditis virus (EMCV) can cause acute myocarditis in various animals including mice. Previously, IDO1 has been reported to have an important immunomodulatory function in immune-related diseases. However, the pathophysiological roles of IDO1 following acute viral infection of central nervous system are not fully understood. We observed that acute EMCV infection leads to a highly reproducible neuronal degeneration in mouse cerebellum. The goal of this study is to determine tissue/cell-specific and time-dependent expressions of IDO1 during acute EMCV infection in mouse cerebellum. IDO1 was up-regulated in microglia, which was recognized to be activated morphologically and positive for ionized calcium-binding adapter molecule 1 (Iba-1), a protein expressed in microglia, within EMCV-induced cerebellar lesions showing neuronal degeneration although the very weak expression of IDO1 is detected only in cytoplasm of Purkinje cells. No GFAP immunostaining was observed in EMCV-induced cerebellar lesions although many reactive astrocytes surrounding the lesions showed strongly positive immunostaining for GFAP 10 days after the viral inoculation. Thus, IDO1 expression may affect EMCV-induced neuronal degeneration in cerebellum.

UR - http://www.scopus.com/inward/record.url?scp=84896106372&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896106372&partnerID=8YFLogxK

U2 - 10.1016/j.neulet.2014.01.051

DO - 10.1016/j.neulet.2014.01.051

M3 - Article

VL - 564

SP - 120

EP - 125

JO - Neuroscience Letters

JF - Neuroscience Letters

SN - 0304-3940

ER -